date:Jul 27, 2023
ch can be used for both proteolytic and non-proteolytic bacteria, she explains.
The current Corbion model is built using a variety of extensive data points, including published scientific literature, in-vitro data, and in-house challenge studies. Currently, the CLMC does not use AI, but it might be a possibility in future models.
With the possibility of developing with AI, Corbion can continue to maintain our industry leadership in this area, Jochems concludes.